Moderna
MRNA
MRNA
885 hedge funds and large institutions have $25.5B invested in Moderna in 2023 Q3 according to their latest regulatory filings, with 82 funds opening new positions, 354 increasing their positions, 302 reducing their positions, and 143 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
13% less funds holding in top 10
Funds holding in top 10: 15 → 13 (-2)
15% less capital invested
Capital invested by funds: $30.2B → $25.5B (-$4.65B)
43% less first-time investments, than exits
New positions opened: 82 | Existing positions closed: 143
Holders
885
Holding in Top 10
13
Calls
$1.71B
Puts
$1.53B
Top Buyers
| 1 | +$189M | |
| 2 | +$107M | |
| 3 | +$95.3M | |
| 4 |
TP
Theleme Partners
London,
United Kingdom
|
+$72.6M |
| 5 |
Goldman Sachs
New York
|
+$70.5M |
Top Sellers
| 1 | -$359M | |
| 2 | -$186M | |
| 3 | -$183M | |
| 4 |
Two Sigma Investments
New York
|
-$78.3M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$69.2M |